This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Kokudo N, Hasegawa K, Akahane M, Igaki H, Izumi N, Ichida T, et al. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res 2015; 45. doi: 10.1111/hepr.12464.KokudoNHasegawaKAkahaneMIgakiHIzumiNIchidaTEvidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)Hepatol Res20154510.1111/hepr.12464Open DOISearch in Google Scholar
Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 2007; 6: 37-48. doi: 10.1177/153303460700600106RubinskyBOnikGMikusPIrreversible electroporation: a new ablation modality—clinical implicationsTechnol Cancer Res Treat20076374810.1177/153303460700600106Open DOISearch in Google Scholar
Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. EJSO 2018; 44: 651-7. doi: 10.1016/j. ejso.2018.01.090DjokicMCemazarMPopovicPKosBDezmanRBosnjakMElectrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot studyEJSO201844651710.1016/jejso.2018.01.090Open DOISearch in Google Scholar
Davalos RV, Mir L, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33: 223. doi: 10.1007/s10439-005-8981-8DavalosRVMirLRubinskyBTissue ablation with irreversible electroporationAnn Biomed Eng20053322310.1007/s10439-005-8981-8Open DOISearch in Google Scholar
Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: 559-65. PMID: 9563546PattersonEJScudamoreCHOwenDANagyAGBuczkowskiAKRadiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion sizeAnn Surg199822755965PMID: 9563546Search in Google Scholar
Rossi S, Garbagnati F, De Francesco I, Accocella F, Leonardi L, Quaretti P, et al. Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori 1999; 85: 128-32. PMID: 10363079RossiSGarbagnatiFDe FrancescoIAccocellaFLeonardiLQuarettiPRelationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularizationTumori19998512832PMID: 10363079Search in Google Scholar
Goldberg SN, Hahn PF, Tanabe KK, Mueller PR, Schima W, Athanasoulis CA, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9(1 Pt 1): 101-11. PMID: 9468403GoldbergSNHahnPFTanabeKKMuellerPRSchimaWAthanasoulisCAPercutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?J Vasc Interv Radiol199891 Pt 110111PMID: 9468403Search in Google Scholar
Goldberg SN, Hahn PF, Halpern EF, Fogle RM, Gazelle GS. Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998; 209: 761-7. doi: 10.1148/radiol-ogy.209.3.9844671GoldbergSNHahnPFHalpernEFFogleRMGazelleGSRadio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameterRadiology1998209761710.1148/radiol-ogy.209.3.9844671Open DOISearch in Google Scholar
Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol 2002; 178: 47-51. doi: 10.2214/ajr.178.1.1780047LuDSRamanSSVodopichDJWangMSayreJLassmanCEffect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effectAJR Am J Roentgenol2002178475110.2214/ajr.178.1.1780047Open DOISearch in Google Scholar
Dollinger M, Beyer LP, Haimerl M, Niessen C, Jung E-M, Zeman F, et al. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience. Diagn Interv Radiol 2015; 21: 471-5. doi: 10.5152/dir.2015.14442DollingerMBeyerLPHaimerlMNiessenCJungE-MZemanFAdverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experienceDiagn Interv Radiol201521471510.5152/dir.2015.14442Open DOISearch in Google Scholar
Frühling P, Nilsson A, Duraj F, Haglund U, Norén A. Single-center non-randomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: short to mid-term results. EJSO 2017; 43: 751-7. doi: 10.1016/j.ejso.2016.12.004FrühlingPNilssonADurajFHaglundUNorén A. Single-center non-randomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: short to mid-term resultsEJSO201743751710.1016/j.ejso.2016.12.004Open DOISearch in Google Scholar
Distelmaier M, Barabasch A, Heil P, Kraemer NA, Isfort P, Keil S, et al. Midterm safety and efficacy of irreversible electroporation of malignant liver tumors located close to major portal or hepatic veins. Radiology 2017; 285: 1023-31. doi: 10.1148/radiol.2017161561DistelmaierMBarabaschAHeilPKraemerNAIsfortPKeilSMidterm safety and efficacy of irreversible electroporation of malignant liver tumors located close to major portal or hepatic veinsRadiology201728510233110.1148/radiol.2017161561Open DOISearch in Google Scholar
Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology 2009; 251: 933-40. doi: 10.1148/radiol.2513081740LiangPWangYYuXDongBMalignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patientsRadiology20092519334010.1148/radiol.2513081740Open DOISearch in Google Scholar
Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol 2011; 21: 2584-96. doi: 10.1007/s00330-011-2222-3BertotLCSatoMTateishiRYoshidaHKoikeKMortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic reviewEur Radiol20112125849610.1007/s00330-011-2222-3Open DOISearch in Google Scholar
Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 2012; 23: 727-36. doi: 10.1016/j.jvir.2012.02.012PatelIJDavidsonJCNikolicBSalazarGMSchwartzbergMSWalkerTGConsensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventionsJ Vasc Interv Radiol2012237273610.1016/j.jvir.2012.02.012Open DOISearch in Google Scholar
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13. doi: 10.1097/01. sla.0000133083.54934.aeDindoDDemartinesNClavienPAClassification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a surveyAnn Surg20042402051310.1097/01sla.0000133083.54934.aeOpen DOISearch in Google Scholar
Sahay A, Sahay N, Kapoor A, Kapoor J, Chatterjee A. Percutaneous image-guided radiofrequency ablation of tumors in inoperable patients - immediate complications and overall safety. Indian J Palliat Care 2016; 22: 67-73. doi: 10.4103/0973-1075.173951SahayASahayNKapoorAKapoorJChatterjeeAPercutaneous image-guided radiofrequency ablation of tumors in inoperable patients - immediate complications and overall safetyIndian J Palliat Care201622677310.4103/0973-1075.173951Open DOISearch in Google Scholar
Carrafiello G, Lagana D, Ianniello A, Dionigi G, Novario R, Recaldini C, et al. Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol 2007; 51: 550-4. doi: 10.1111/j.1440-1673.2007.01871.xCarrafielloGLaganaDIannielloADionigiGNovarioRRecaldiniCPost-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published worksAustralas Radiol200751550410.1111/j.1440-1673.2007.01871.xOpen DOISearch in Google Scholar
Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20(7 Suppl): S377-90. doi: 10.1016/j.jvir.2009.04.011GoldbergSNGrassiCJCardellaJFCharboneauJWDoddGDDupuyDEImage-guided tumor ablation: standardization of terminology and reporting criteriaJ Vasc Interv Radiol2009207 SupplS3779010.1016/j.jvir.2009.04.011Open DOISearch in Google Scholar
Feher J, Lengyel G. [Hepatocellular carcinoma: occurrence, risk factors, biomarkers]. Orv Hetil 2010; 151: 933-40. doi: 10.1556/oh.2010.28900FeherJLengyelG[Hepatocellular carcinoma: occurrence, risk factors, biomarkers]Orv Hetil20101519334010.1556/oh.2010.28900Open DOISearch in Google Scholar
Statistisches-Bundesamt. Diagnosedaten der krankenhäuser ab 2000 zweigstelle bonn june 2017 [updated 12. 06. 2017]. Available from: http://www.gbe-bund.deStatistisches-Bundesamt. Diagnosedaten der krankenhäuser ab2000zweigstelle bonn june 2017 [updated 12. 06. 2017]Available fromhttp://www.gbe-bund.deSearch in Google Scholar
Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB 2010; 12: 289-99. doi: 10.1111/j.1477-2574.2010.00181.x.VautheyJNDixonEAbdallaEKHeltonWSPawlikTMTaouliBPretreatment assessment of hepatocellular carcinoma: expert consensus statementHPB2010122899910.1111/j.1477-2574.2010.00181.xOpen DOISearch in Google Scholar
Malek NP, Schmidt S, Huber P, Manns MP, Greten TF. The diagnosis and treatment of hepatocellular carcinoma. Dtsch Arztebl Int 2014; 111: 101-6. doi: 10.3238/arztebl.2014.0101.MalekNPSchmidtSHuberPMannsMPGretenTFThe diagnosis and treatment of hepatocellular carcinomaDtsch Arztebl Int2014111101610.3238/arztebl.2014.0101Open DOISearch in Google Scholar
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236. doi: 10.1016/j.jhep.2018.03.019EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJ Hepatol20186918223610.1016/j.jhep.2018.03.019Open DOISearch in Google Scholar
Raza A, Sood GK. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol 2014; 20: 4115-27. doi: 10.3748/wjg.v20.i15.4115RazaASoodGKHepatocellular carcinoma review: current treatment, and evidence-based medicineWorld J Gastroenterol 20142041152710.3748/wjg.v20.i15.4115Open DOISearch in Google Scholar
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36. doi: 10.1002/hep.24199BruixJShermanMManagement of hepatocellular carcinomaHepatology20054212083610.1002/hep.24199Open DOISearch in Google Scholar
Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52 (Suppl 3): iii1-8. doi: 10.1016/j. jvir.2013.09.005RyderSDGuidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adultsGut200352Suppl 3iii1-810.1016/jjvir.2013.09.005Open DOISearch in Google Scholar
Ikai I, Kudo M, Arii S, Omata M, Kojiro M, Sakamoto M, et al. Report of the 18th follow-up survey of primary liver cancer in Japan. Hepatol Res 2010; 40: 1043-59. doi: 10.1111/j.1872-034X.2010.00731.xIkaiIKudoMAriiSOmataMKojiroMSakamotoMReport of the 18th follow-up survey of primary liver cancer in JapanHepatol Res20104010435910.1111/j.1872-034X.2010.00731.xOpen DOISearch in Google Scholar
Andreano A, Galimberti S, Franza E, Knavel EM, Sironi S, Lee FT, et al. Percutaneous microwave ablation of hepatic tumors: prospective evaluation of postablation syndrome and postprocedural pain. J Vasc Interv Radiol 2014; 25: 97-105. e2. doi: 10.1016/j.jvir.2013.09.005AndreanoAGalimbertiSFranzaEKnavelEMSironiSLeeFTPercutaneous microwave ablation of hepatic tumors: prospective evaluation of postablation syndrome and postprocedural painJ Vasc Interv Radiol20142597105e210.1016/j.jvir.2013.09.005Open DOISearch in Google Scholar
Dodd GD, 3rd, Napier D, Schoolfield JD, Hubbard L. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol 2005; 185: 51-7. doi: 10.2214/ajr.185.1.01850051DoddGD 3rdNapierDSchoolfieldJDHubbardLPercutaneous radiofrequency ablation of hepatic tumors: postablation syndromeAJR Am J Roentgenol200518551710.2214/ajr.185.1.01850051Open DOISearch in Google Scholar
Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-51. doi: 10.1148/radiol.2262012198LivraghiTSolbiatiLMeloniMFGazelleGSHalpernEFGoldbergSNTreatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter studyRadiology20032264415110.1148/radiol.2262012198Open DOISearch in Google Scholar
Fruhling P, Nilsson A, Duraj F, Haglund U, Noren A. Single-center non-randomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results. Eur J Surg Oncol 2017; 43: 751-7. doi: 10.1016/j.ejso.2016.12.004FruhlingPNilssonADurajFHaglundUNorenASingle-center non-randomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term resultsEur J Surg Oncol201743751710.1016/j.ejso.2016.12.004Open DOISearch in Google Scholar
Zeng J, Liu G, Li ZH, Yang Y, Fang G, Li RR, et al. The safety and efficacy of irreversible electroporation for large hepatocellular carcinoma. Technol Cancer Res Treat 2017; 16: 120-4. doi: 10.1177/1533034616676445ZengJLiuGLiZHYangYFangGLiRRThe safety and efficacy of irreversible electroporation for large hepatocellular carcinomaTechnol Cancer Res Treat201716120410.1177/1533034616676445Open DOISearch in Google Scholar
Omary RA, Bettmann MA, Cardella JF, Bakal CW, Schwartzberg MS, Sacks D, et al. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 2003; 14(9 Pt 2): S293-5. PMID: 12354820OmaryRABettmannMACardellaJFBakalCWSchwartzbergMSSacksDQuality improvement guidelines for the reporting and archiving of interventional radiology proceduresJ Vasc Interv Radiol2003149 Pt 2S2935PMID: 12354820Search in Google Scholar